Which has higher valuation and earnings, VHI or KSI?

Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vitalhub C$119.20M 3.81 C$3.35M C$0.12 59.83 kneat.com C$66.52M 9.31 -C$8.62M -C$0.08 N/A

Is VHI or KSI more profitable?

Vitalhub has a net margin of 6.13% compared to kneat.com's net margin of -12.69%. Vitalhub's return on equity of 2.98% beat kneat.com's return on equity. Company Net Margins Return on Equity Return on Assets Vitalhub 6.13% 2.98% 3.81% kneat.com -12.69% -12.95% -9.84%

Does the media favor VHI or KSI?

In the previous week, kneat.com had 5 more articles in the media than Vitalhub. MarketBeat recorded 7 mentions for kneat.com and 2 mentions for Vitalhub. Vitalhub's average media sentiment score of -0.08 beat kneat.com's score of -0.52 indicating that Vitalhub is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vitalhub 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral kneat.com 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts recommend CARE or KSI?

kneat.com has a consensus price target of C$6.30, suggesting a potential downside of 2.17%. Given Dialogue Health Technologies' higher probable upside, analysts plainly believe Dialogue Health Technologies is more favorable than kneat.com. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dialogue Health Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 kneat.com 2 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer RHT or KSI?

kneat.com has a consensus target price of C$6.30, indicating a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than Reliq Health Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reliq Health Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 kneat.com 2 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts recommend ADK or KSI?

kneat.com has a consensus price target of C$6.30, suggesting a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than DIAGNOS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DIAGNOS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 kneat.com 2 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, ADK or KSI?

DIAGNOS has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than DIAGNOS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DIAGNOS C$68.16K 349.99 -C$3.81M -C$0.05 N/A kneat.com C$66.52M 9.31 -C$8.62M -C$0.08 N/A

Is ADK or KSI more profitable?

kneat.com has a net margin of -12.69% compared to DIAGNOS's net margin of -6,907.32%. DIAGNOS's return on equity of 3,086.87% beat kneat.com's return on equity. Company Net Margins Return on Equity Return on Assets DIAGNOS -6,907.32% 3,086.87% -134.33% kneat.com -12.69% -12.95% -9.84%

Do analysts recommend KSI or DOC?

kneat.com currently has a consensus target price of C$6.30, indicating a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher probable upside, analysts plainly believe kneat.com is more favorable than CloudMD Software & Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score kneat.com 2 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 CloudMD Software & Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

kneat.com (KSI) Competitors

C$6.44 0.00 (0.00%)

As of 06/12/2026 04:00 PM Eastern

Compare

KSI vs. VHI, CARE, RHT, ADK, and DOC

Should you buy kneat.com stock or one of its competitors? MarketBeat compares kneat.com with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), and CloudMD Software & Services (DOC). These companies are all part of the "health information services" industry.

How does kneat.com compare to Vitalhub?

Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

Vitalhub has a beta of 0.879411, indicating that its share price is 12% less volatile than the broader market. Comparatively, kneat.com has a beta of 1.183182, indicating that its share price is 18% more volatile than the broader market.

Vitalhub currently has a consensus price target of C$13.14, indicating a potential upside of 83.05%. kneat.com has a consensus price target of C$6.30, indicating a potential downside of 2.17%. Given Vitalhub's stronger consensus rating and higher possible upside, equities research analysts clearly believe Vitalhub is more favorable than kneat.com.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14
kneat.com	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

26.1% of Vitalhub shares are owned by institutional investors. Comparatively, 4.8% of kneat.com shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by company insiders. Comparatively, 26.0% of kneat.com shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, kneat.com had 5 more articles in the media than Vitalhub. MarketBeat recorded 7 mentions for kneat.com and 2 mentions for Vitalhub. Vitalhub's average media sentiment score of -0.08 beat kneat.com's score of -0.52 indicating that Vitalhub is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vitalhub	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
kneat.com	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vitalhub	C$119.20M	3.81	C$3.35M	C$0.12	59.83
kneat.com	C$66.52M	9.31	-C$8.62M	-C$0.08	N/A

Vitalhub has a net margin of 6.13% compared to kneat.com's net margin of -12.69%. Vitalhub's return on equity of 2.98% beat kneat.com's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vitalhub	6.13%	2.98%	3.81%
kneat.com	-12.69%	-12.95%	-9.84%

Summary

Vitalhub beats kneat.com on 13 of the 17 factors compared between the two stocks.

How does kneat.com compare to Dialogue Health Technologies?

Dialogue Health Technologies (TSE:CARE) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

kneat.com has a net margin of -12.69% compared to Dialogue Health Technologies' net margin of -19.73%. kneat.com's return on equity of -12.95% beat Dialogue Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dialogue Health Technologies	-19.73%	-19.76%	-10.01%
kneat.com	-12.69%	-12.95%	-9.84%

Dialogue Health Technologies has a beta of 2.66, meaning that its share price is 166% more volatile than the broader market. Comparatively, kneat.com has a beta of 1.183182, meaning that its share price is 18% more volatile than the broader market.

kneat.com has a consensus price target of C$6.30, suggesting a potential downside of 2.17%. Given Dialogue Health Technologies' higher probable upside, analysts plainly believe Dialogue Health Technologies is more favorable than kneat.com.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dialogue Health Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
kneat.com	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

kneat.com has lower revenue, but higher earnings than Dialogue Health Technologies. kneat.com is trading at a lower price-to-earnings ratio than Dialogue Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dialogue Health Technologies	C$95.88M	0.00	-C$19.50M	-C$0.30	N/A
kneat.com	C$66.52M	9.31	-C$8.62M	-C$0.08	N/A

In the previous week, kneat.com had 7 more articles in the media than Dialogue Health Technologies. MarketBeat recorded 7 mentions for kneat.com and 0 mentions for Dialogue Health Technologies. Dialogue Health Technologies' average media sentiment score of 0.00 beat kneat.com's score of -0.52 indicating that Dialogue Health Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Dialogue Health Technologies	Neutral
kneat.com	Negative

47.0% of Dialogue Health Technologies shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 11.7% of Dialogue Health Technologies shares are held by insiders. Comparatively, 26.0% of kneat.com shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

kneat.com beats Dialogue Health Technologies on 9 of the 15 factors compared between the two stocks.

How does kneat.com compare to Reliq Health Technologies?

Reliq Health Technologies (CVE:RHT) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

Reliq Health Technologies has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, kneat.com has a beta of 1.183182, suggesting that its share price is 18% more volatile than the broader market.

kneat.com has a consensus target price of C$6.30, indicating a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than Reliq Health Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reliq Health Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
kneat.com	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Reliq Health Technologies has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Reliq Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reliq Health Technologies	N/A	N/A	N/A	-C$0.02	N/A
kneat.com	C$66.52M	9.31	-C$8.62M	-C$0.08	N/A

In the previous week, kneat.com had 7 more articles in the media than Reliq Health Technologies. MarketBeat recorded 7 mentions for kneat.com and 0 mentions for Reliq Health Technologies. Reliq Health Technologies' average media sentiment score of 0.00 beat kneat.com's score of -0.52 indicating that Reliq Health Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Reliq Health Technologies	Neutral
kneat.com	Negative

2.8% of Reliq Health Technologies shares are owned by institutional investors. Comparatively, 4.8% of kneat.com shares are owned by institutional investors. 1.8% of Reliq Health Technologies shares are owned by insiders. Comparatively, 26.0% of kneat.com shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

kneat.com has a net margin of -12.69% compared to Reliq Health Technologies' net margin of -95.54%. kneat.com's return on equity of -12.95% beat Reliq Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Reliq Health Technologies	-95.54%	-221.64%	-5.30%
kneat.com	-12.69%	-12.95%	-9.84%

Summary

kneat.com beats Reliq Health Technologies on 9 of the 14 factors compared between the two stocks.

How does kneat.com compare to DIAGNOS?

DIAGNOS (CVE:ADK) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

DIAGNOS has a beta of -0.020552, meaning that its share price is 102% less volatile than the broader market. Comparatively, kneat.com has a beta of 1.183182, meaning that its share price is 18% more volatile than the broader market.

kneat.com has a net margin of -12.69% compared to DIAGNOS's net margin of -6,907.32%. DIAGNOS's return on equity of 3,086.87% beat kneat.com's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DIAGNOS	-6,907.32%	3,086.87%	-134.33%
kneat.com	-12.69%	-12.95%	-9.84%

DIAGNOS has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than DIAGNOS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DIAGNOS	C$68.16K	349.99	-C$3.81M	-C$0.05	N/A
kneat.com	C$66.52M	9.31	-C$8.62M	-C$0.08	N/A

kneat.com has a consensus price target of C$6.30, suggesting a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than DIAGNOS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DIAGNOS	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
kneat.com	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

0.3% of DIAGNOS shares are owned by institutional investors. Comparatively, 4.8% of kneat.com shares are owned by institutional investors. 16.8% of DIAGNOS shares are owned by insiders. Comparatively, 26.0% of kneat.com shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, kneat.com had 7 more articles in the media than DIAGNOS. MarketBeat recorded 7 mentions for kneat.com and 0 mentions for DIAGNOS. DIAGNOS's average media sentiment score of 0.00 beat kneat.com's score of -0.52 indicating that DIAGNOS is being referred to more favorably in the media.

Company	Overall Sentiment
DIAGNOS	Neutral
kneat.com	Negative

Summary

kneat.com beats DIAGNOS on 10 of the 16 factors compared between the two stocks.

How does kneat.com compare to CloudMD Software & Services?

kneat.com (TSE:KSI) and CloudMD Software & Services (CVE:DOC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

kneat.com has higher earnings, but lower revenue than CloudMD Software & Services. kneat.com is trading at a lower price-to-earnings ratio than CloudMD Software & Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
kneat.com	C$66.52M	9.31	-C$8.62M	-C$0.08	N/A
CloudMD Software & Services	C$90.91M	0.12	-C$76.56M	-C$0.23	N/A

4.8% of kneat.com shares are held by institutional investors. Comparatively, 0.5% of CloudMD Software & Services shares are held by institutional investors. 26.0% of kneat.com shares are held by company insiders. Comparatively, 0.1% of CloudMD Software & Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

kneat.com has a net margin of -12.69% compared to CloudMD Software & Services' net margin of -91.12%. kneat.com's return on equity of -12.95% beat CloudMD Software & Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
kneat.com	-12.69%	-12.95%	-9.84%
CloudMD Software & Services	-91.12%	-102.91%	-8.74%

kneat.com currently has a consensus target price of C$6.30, indicating a potential downside of 2.17%. Given kneat.com's stronger consensus rating and higher probable upside, analysts plainly believe kneat.com is more favorable than CloudMD Software & Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
kneat.com	2 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
CloudMD Software & Services	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

kneat.com has a beta of 1.183182, meaning that its share price is 18% more volatile than the broader market. Comparatively, CloudMD Software & Services has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

In the previous week, kneat.com had 7 more articles in the media than CloudMD Software & Services. MarketBeat recorded 7 mentions for kneat.com and 0 mentions for CloudMD Software & Services. CloudMD Software & Services' average media sentiment score of 0.00 beat kneat.com's score of -0.52 indicating that CloudMD Software & Services is being referred to more favorably in the news media.

Company	Overall Sentiment
kneat.com	Negative
CloudMD Software & Services	Neutral

Summary

kneat.com beats CloudMD Software & Services on 11 of the 16 factors compared between the two stocks.

Get kneat.com News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KSI vs. The Competition

Export

Metric	kneat.com	Health Information Services Industry	Medical Sector	TSE Exchange
Market Cap	C$619.09M	C$347.34M	C$6.52B	C$12.19B
Dividend Yield	N/A	5.60%	2.67%	6.19%
P/E Ratio	-80.50	223.74	24.00	36.94
Price / Sales	9.31	129.86	514.65	10.45
Price / Cash	13.18	47.14	27.48	82.29
Price / Book	9.78	5.59	10.69	4.47
Net Income	-C$8.62M	-C$22.78M	C$3.57B	C$299.09M
7 Day Performance	0.16%	0.03%	0.61%	0.65%
1 Month Performance	26.77%	2.67%	1.56%	-0.08%
1 Year Performance	-2.72%	-8.51%	25.44%	41.90%

kneat.com Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KSI kneat.com	0.3352 of 5 stars	C$6.44 flat	C$6.30 -2.2%	-2.7%	C$619.09M	C$66.52M	N/A	293	High Trading Volume
VHI Vitalhub	3.1898 of 5 stars	C$7.14 +0.8%	C$13.14 +84.1%	-34.7%	C$451.68M	C$119.20M	59.50	2,250
CARE Dialogue Health Technologies	N/A	N/A	N/A	N/A	C$345.36M	C$95.88M	N/A	730
RHT Reliq Health Technologies	N/A	C$0.22 flat	N/A	+0.0%	C$46.65M	N/A	N/A	12,600
ADK DIAGNOS	N/A	C$0.19 -5.0%	N/A	+0.0%	C$22.66M	C$68.16K	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:KSI) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

kneat.com (KSI) Competitors

KSI vs. VHI, CARE, RHT, ADK, and DOC

How does kneat.com compare to Vitalhub?

Summary

How does kneat.com compare to Dialogue Health Technologies?

Summary

How does kneat.com compare to Reliq Health Technologies?

Summary

How does kneat.com compare to DIAGNOS?

Summary

How does kneat.com compare to CloudMD Software & Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KSI vs. The Competition

kneat.com Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

kneat.com (KSI) Competitors

KSI vs. VHI, CARE, RHT, ADK, and DOC

How does kneat.com compare to Vitalhub?

Which has more risk and volatility, VHI or KSI?

Do analysts prefer VHI or KSI?

Do institutionals and insiders believe in VHI or KSI?

Does the media favor VHI or KSI?

Which has higher valuation and earnings, VHI or KSI?

Is VHI or KSI more profitable?

Summary

How does kneat.com compare to Dialogue Health Technologies?

Is CARE or KSI more profitable?

Which has more volatility & risk, CARE or KSI?

Do analysts recommend CARE or KSI?

Which has better valuation and earnings, CARE or KSI?

Does the media favor CARE or KSI?

Do insiders and institutionals have more ownership in CARE or KSI?

Summary

How does kneat.com compare to Reliq Health Technologies?

Which has more risk & volatility, RHT or KSI?

Do analysts prefer RHT or KSI?

Which has better earnings & valuation, RHT or KSI?

Does the media favor RHT or KSI?

Do institutionals & insiders have more ownership in RHT or KSI?

Is RHT or KSI more profitable?

Summary

How does kneat.com compare to DIAGNOS?

Which has more risk and volatility, ADK or KSI?

Is ADK or KSI more profitable?

Which has preferable valuation and earnings, ADK or KSI?

Do analysts recommend ADK or KSI?

Do institutionals & insiders hold more shares of ADK or KSI?

Does the media favor ADK or KSI?

Summary

How does kneat.com compare to CloudMD Software & Services?

Which has higher valuation and earnings, KSI or DOC?

Do insiders and institutionals hold more shares of KSI or DOC?

Is KSI or DOC more profitable?

Do analysts recommend KSI or DOC?

Which has more volatility and risk, KSI or DOC?

Does the media prefer KSI or DOC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KSI vs. The Competition

kneat.com Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools